ArticleNucleic acids research2026
High-throughput functional profiling and evolutionary covariation analysis of entire riboswitch sequences.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
Abstract
Riboswitches are useful models for revealing how some RNA molecules undergo dynamic rearrangements of their structures to perform cellular functions. A great deal is known about riboswitch aptamer domains through sequence covariation analysis, which has been difficult to apply to expression platforms given their large sequence diversity. Here, we develop an approach to generate covariation models for entire riboswitch sequences including the aptamer domain and the expression platform. The method consists of bioinformatically extending aptamer domains to include downstream sequences and filtering these sequences using either computational or high-throughput experimental approaches to identify those that include bacterial intrinsic terminators. Filtered sequences are then used to generate covariation models. We developed this approach in the context of the fluoride riboswitch, characterizing 1901 fluoride riboswitch sequences using high-throughput in vitro transcription followed by next-generation sequencing, and generating a covarion model consistent with its mechanism. We then developed covariation models of the ZTP, lysine, and TPP riboswitches and find covariation support for previously published mechanisms. Our method represents a new approach to characterizing large numbers of riboswitch sequences and to generate covariation models of complete riboswitches, which should expand our understanding of riboswitch mechanisms and the evolution of RNA structure dynamics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.